Gerke, Pezzulo awarded five-year, $3.8M R01
Sarcoidosis is a systemic inflammatory disease of unknown cause that can affect the lungs in more than 90% of cases. Severe manifestations of lung inflammation and fibrosis significantly impair quality of life and can lead to lung transplant or death. Associate Professors of Pulmonary, Critical Care, and Occupational Medicine, Alicia Gerke, MD, MBA, and Alejandro A. Pezzulo, MD, have secured a grant from the National Heart, Lung, and Blood Institute (NHLBI) to investigate environmental exposures that drive this disease. This five-year, $3.8 million R01 award will fund their project titled “The Role of Residential Bioaerosol Exposure in Pulmonary Sarcoidosis.”
Sarcoidosis disproportionately affects African Americans, women, and the elderly. Mortality has increased over time in the United States, particularly in those with lung disease. Treatments are currently limited to medications that blunt the inflammatory response, with considerable side effects.
“Environmental exposures have long been thought to contribute to the development of sarcoidosis, but the exact cause remains unknown,” Gerke said. “Until we understand what those factors are and how they impact disease course, we will continue to be limited in finding a cure or a way to prevent the disease.”
The suspected triggers of pulmonary sarcoidosis are specific molecules on the surface of airborne particles that include pollen, mold, spores, bacteria, and viruses. Upon contact with these particles, the epithelial cells that line the airways and the immune cells in the lungs initiate an inflammatory response. In people with sarcoidosis, this response may be exaggerated or fail to resolve; however, much remains unknown about whether persistent exposure to triggers or a persistent inflammatory response drives disease progression.
People may encounter these particles in their own homes and day-to-day environments. Gerke and Pezzulo hypothesize that these residential exposures drive the severity of pulmonary sarcoidosis.
Gerke and Pezzulo will analyze the levels and specific composition of household bioaerosols and their relationships to symptoms, lung function, and imaging findings of pulmonary sarcoidosis. They will also investigate whether airway epithelial and circulating immune cell responses to home airborne particles and their components associate with the clinical outcomes. These results will clarify the disease mechanism and could inform more effective treatment strategies that address environmental hazards in people’s homes, thereby preventing disease progression.
“Finding environmental factors that either cause or propagate this disease will be fundamental to achieve better outcomes for patients afflicted with sarcoidosis,” Gerke said. “Understanding the mechanisms by which progression occurs will inform new treatment paradigms which could include environmental remediation. Additionally, we will be able to uncover new treatment options that are less immunosuppressive and more tolerable to those with progressive disease.”
Pezzulo and Gerke would like to thank Emma Thornell, PhD, for her work in the project’s preliminary data and writing.